Canadian Pharmaceuticals & Biotech Most Popular Stocks

Curaleaf Holdings

Market Cap: CA$2.6b

Produces and distributes cannabis products in the United States and internationally.

Green Thumb Industries

Market Cap: CA$2.6b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Trulieve Cannabis

Market Cap: CA$1.9b

Operates as a cannabis retailer.

Cronos Group

Market Cap: CA$1.4b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Bright Minds Biosciences

Market Cap: CA$1.0b

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Vireo Growth

Market Cap: CA$885.9m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.

Cresco Labs

Market Cap: CA$736.8m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

NervGen Pharma

Market Cap: CA$622.4m

A biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.

Verano Holdings

Market Cap: CA$613.9m

Operates as a vertically integrated multi-state cannabis operator in the United States.

Knight Therapeutics

Market Cap: CA$597.7m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Canopy Growth

Market Cap: CA$568.0m

Engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia.

Eupraxia Pharmaceuticals

Market Cap: CA$517.6m

A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.

Spectral Medical

Market Cap: CA$406.6m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

TerrAscend

Market Cap: CA$397.2m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Cipher Pharmaceuticals

Market Cap: CA$371.3m

Operates as a specialty pharmaceutical company in Canada.

Aurora Cannabis

Market Cap: CA$334.0m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

High Tide

Market Cap: CA$322.3m

Engages in the cannabis retail business in Canada.

Organigram Global

Market Cap: CA$317.3m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

Auxly Cannabis Group

Market Cap: CA$195.5m

Operates as a consumer packaged goods company in the cannabis products market in Canada.

Helix BioPharma

Market Cap: CA$170.3m

A clinical-stage biopharmaceutical company developing therapies in the field of immune-oncology in Canada.

Grown Rogue International

Market Cap: CA$149.8m

A craft cannabis company, focuses on premium flower and flower-derived products.

HLS Therapeutics

Market Cap: CA$148.9m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.

Satellos Bioscience

Market Cap: CA$146.6m

A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.

BioSyent

Market Cap: CA$142.0m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Cardiol Therapeutics

Market Cap: CA$139.4m

A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

ME Therapeutics Holdings

Market Cap: CA$114.2m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

Atlas Energy

Market Cap: CA$100.7m

A biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States.

Medexus Pharmaceuticals

Market Cap: CA$93.8m

Operates as a pharmaceutical company in Canada and the United States.

Planet 13 Holdings

Market Cap: CA$89.5m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Medicenna Therapeutics

Market Cap: CA$79.2m

A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.

MTL Cannabis

Market Cap: CA$78.2m

Through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada.

BioNxt Solutions

Market Cap: CA$77.2m

Engages in research, development, manufacture, and sale of next generation drug formulations and delivery systems in Austria, Germany, and Switzerland.

Charlotte's Web Holdings

Market Cap: CA$75.7m

Engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products.

Onco-Innovations

Market Cap: CA$73.6m

A pre-clinical stage biotechnology company, develops drug candidates for cancer treatments.

C21 Investments

Market Cap: CA$62.5m

An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States.

LIR Life Sciences

Market Cap: CA$61.0m

Operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders.